Product Images Drospirenone And Ethinyl Estradiol

This is a chart showing the number of women out of 10,000 women years (WY) who had a blood clot based on their pregnancy status (non-pregnant, non-COC user, pregnant, or postpartum). The chart also displays percentages for the different ranges of non-COC users. The pregnancy data is based on actual pregnancy duration, and the assumed rate is between 7 to 27 per 10,000 WY.*

Drospirenone Ethinyl estradiol is a combination of female hormones that prevent ovulation (the release of an egg from an ovary). This medication also causes changes in your cervical mucus and uterine lining, making it harder for sperm to reach the uterus and harder for a fertilized egg to attach to the uterus. Drospirenone Ethinyl estradiol is used as contraception to prevent pregnancy.*

This is a chart or table showing the effectiveness of various birth control methods, categorized by the number of pregnancies per 100 women in one year. The methods listed include hormonal methods such as birth control pills, patches, injections, and vaginal rings, as well as non-hormonal methods such as condoms, diaphragms, and fertility awareness methods like tracking fertile days and withdrawal. The chart also includes long-term options like intrauterine devices and sterilization. The effectiveness varies widely depending on the method, with some having an effectiveness rate of fewer than 1 pregnancy per 100 women per year and others having a rate of 85 or more pregnancies per 100 women per year.*

This text appears to be a product label or a prescription for a medication named "LUPIN". The label includes the dose of medication (0.03 mg) and the days of the week for taking it. It also includes the address of the pharmacy or the manufacturer where it was prepared, which is located at VX3 1SY3HE 4138 ATHINOW. Finally, it includes a storage instruction to keep the medication at 25°C and details about the permitted temperature range.*

This is a chart that shows the percentage of blood clot incidents in non-pregnant women who are non-users and users of COC, and in pregnant women or women who are postpartum (only up to 12 weeks). The chart shows varying percentages for different groups. The data for pregnancy is based on actual pregnancy duration in reference studies and has a rate of 7 to 27 per 10,000 WY based on a model assumption of pregnancy duration for nine months.*

This is a description of a medication called Drospirenone and Ethinyl Estradiol Tablets USP containing 3 mg/0.03 mg. It is produced by a company called SafeL 82 and has an NDC code of 68180-902-11. The medication needs to be kept out of the reach of children and is stored at a temperature of 25°C with excursions permitted between 15°C to 30°C (59°F to 86°F). The other text includes some alphanumeric codes, which are not available for interpretation.*

This appears to be a mixture of text and numbers that do not fit into a useful description. It is not available.*